A medicinal product not subject to medical prescription in one Member State may not be placed on the market in another Member State unless that Member State, too, or the European Commission, has granted its marketing authorisation, the Court of Justice of the European Union recalled in a judgment handed down on Thursday 8 July (case C-178/20).
The Hungarian company Pharma Expressz is challenging, in the Hungarian courts, the prohibition on continuing to market in Hungary, without complying...